Results 61 to 70 of about 22,104,819 (333)

Inhibition of dipeptidyl peptidase 7 impairs lysophagy in LLOMe‐treated HepG2 cells

open access: yesFEBS Letters, EarlyView.
DPP7 inhibition delays ubiquitin‐dependent lysophagy by attenuating ubiquitin accumulation and the recruitment of SQSTM1 and LC3 to damaged lysosomes, resulting in delayed clearance of damaged lysosomes and impaired restoration of lysosomal homeostasis. Created using FigureLabs (Certificate ID: FL‐PUB‐20260922‐Z99XNX).
Na Yeon Park   +8 more
wiley   +1 more source

A Simple and Efficient Preparation of Penicillin V β-Sulfoxide

open access: yes, 1986
Penicillin V (1) can be oxidized to the β- sulfoxide (2) in high yield in a two-phase mixture of dichloromethane and aqueous hydrogen peroxide. The addition of acids or metallic catalysts is not necessary.
M Davis, WY Wu
core   +1 more source

Antibiotična terapija ob porodu – priporočila

open access: yesZdravniški Vestnik, 2019
Antibiotike v času poroda uporabljamo za preprečevanje in zdravljenje okužb pri materi ter za preprečevanje okužb pri novorojenčkih. Kratkotrajna terapija med porodom se uporablja za preprečevanje okužb s streptokokom skupine B (SSB) pri novorojenčkih ...
Vesna Fabjan Vodušek   +6 more
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

SILVER NANOPARTICLES AS PENICILLIN ACTION ENHANCERS [PDF]

open access: yesBiotechnologia Acta, 2013
Nowadays, the value of bactericidal nanomaterials research increases at the increasing number of bacteria strains resistant to the most highly potent antibiotics. In the review the characteristic of nanoparticles and methods for their production are done.
O. A. Vasylchenko   +2 more
doaj   +1 more source

Ciprofloxacin, enrofloxacin, lincomycin, penicillin G, and penicillin V – Determination of selected antibiotics in urine by LC‐MS/MS. Biomonitoring Method [PDF]

open access: yes, 2022
The working group “Analyses in Biological Materials” of the Permanent Senate Com- mission for the Investigation of Health Hazards of Chemical Compounds in the Work Area developed and verified the presented biomonitoring method. This method allows for the
Hartwig, Andrea; https://orcid.org/   +8 more
core   +1 more source

Resistance of Vibrio cholera to antibiotics that inhibit cell wall synthesis: A systematic review and meta-analysis

open access: yesFrontiers in Pharmacology, 2023
Objective: Cholera is a challenging ancient disease caused by Vibrio cholera (V. cholera). Antibiotics that prevent cell wall synthesis are among the first known antibiotic groups. Due to its high consumption, V.
Hossein Nateghizad   +6 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

ESTIMATION OF ANTIBIOTICS, SULPHONAMIDES AND NITROFURANS RESIDUES IN CHICKEN MEAT [PDF]

open access: yesAssiut Veterinary Medical Journal, 1998
Fourty chicken muscle, ten liver and ten kidney samples were collected randomly from Assiut Governorate and analyzed for antibiotic, sulphonamide and nitrofuran residues.
D.A. Salem
doaj   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy